Wunderlich Capital Managemnt’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $1.03M | Buy |
6,003
+48
| +0.8% | +$7.95K | 0.46% | 60 |
|
|
2024
Q1 | $1.08M | Sell |
5,955
-318
| -5% | -$54.8K | 0.49% | 61 |
|
|
2023
Q4 | $972K | Sell |
6,273
-1,307
| -17% | -$191K | 0.44% | 63 |
|
|
2023
Q3 | $1.13M | Buy |
7,580
+15
| +0.2% | +$2.2K | 0.56% | 56 |
|
|
2023
Q2 | $1.02M | Buy |
7,565
+222
| +3% | +$32.6K | 0.5% | 58 |
|
|
2023
Q1 | $1.17M | Buy |
7,343
+198
| +3% | +$30.3K | 0.61% | 61 |
|
|
2022
Q4 | $1.16M | Buy |
7,145
+134
| +2% | +$20.5K | 0.64% | 60 |
|
|
2022
Q3 | $941K | Buy |
7,011
+561
| +9% | +$80.5K | 0.6% | 61 |
|
|
2022
Q2 | $988K | Sell |
6,450
-49
| -0.8% | -$7.49K | 0.58% | 63 |
|
|
2022
Q1 | $1.05M | Buy |
6,499
+26
| +0.4% | +$3.78K | 0.5% | 67 |
|
|
2021
Q4 | $876K | Buy |
+6,473
| New | +$765K | 0.39% | 71 |
|
|
2019
Q2 | – | Sell |
-20,088
| Closed | -$1.62M | – | 89 |
|
|
2019
Q1 | $1.62M | Buy |
20,088
+375
| +2% | +$30.7K | 1.13% | 46 |
|
|
2018
Q4 | $1.82M | Sell |
19,713
-49
| -0.2% | -$4.31K | 1.4% | 21 |
|
|
2018
Q3 | $1.87M | Sell |
19,762
-1,021
| -5% | -$96.8K | 1.33% | 29 |
|
|
2018
Q2 | $1.93M | Sell |
20,783
-117
| -0.6% | -$11.4K | 1.34% | 23 |
|
|
2018
Q1 | $1.98M | Sell |
20,900
-2,705
| -11% | -$297K | 1.36% | 18 |
|
|
2017
Q4 | $2.28M | Sell |
23,605
-74
| -0.3% | -$6.97K | 1.58% | 10 |
|
|
2017
Q3 | $2.1M | Sell |
23,679
-538
| -2% | -$41K | 1.57% | 11 |
|
|
2017
Q2 | $1.76M | Sell |
24,217
-488
| -2% | -$32.8K | 1.31% | 23 |
|
|
2017
Q1 | $1.61M | Buy |
24,705
+220
| +0.9% | +$13.8K | 1.26% | 29 |
|
|
2016
Q4 | $1.53M | Sell |
24,485
-160
| -0.6% | -$9.77K | 1.25% | 32 |
|
|
2016
Q3 | $1.55M | Buy |
24,645
+573
| +2% | +$37.1K | 1.24% | 29 |
|
|
2016
Q2 | $1.49M | Buy |
24,072
+380
| +2% | +$23.2K | 1.26% | 29 |
|
|
2016
Q1 | $1.35M | Buy |
23,692
+361
| +2% | +$20.1K | 1.16% | 44 |
|
|
2015
Q4 | $1.38M | Buy |
23,331
+1,074
| +5% | +$61.9K | 1.19% | 35 |
|
|
2015
Q3 | $1.21M | Sell |
22,257
-135
| -0.6% | -$8.79K | 1.12% | 41 |
|
|
2015
Q2 | $1.5M | Sell |
22,392
-155
| -0.7% | -$10.1K | 1.46% | 17 |
|
|
2015
Q1 | $1.31M | Sell |
22,547
-490
| -2% | -$29.6K | 1.18% | 35 |
|
|
2014
Q4 | $1.51M | Buy |
23,037
+86
| +0.4% | +$5.42K | 1.28% | 18 |
|
|
2014
Q3 | $1.32M | Buy |
22,951
+68
| +0.3% | +$3.77K | 1.19% | 28 |
|
|
2014
Q2 | $1.29M | Buy |
22,883
+201
| +0.9% | +$10.5K | 1.18% | 36 |
|
|
2014
Q1 | $1.17M | Buy |
22,682
+161
| +0.7% | +$8.14K | 1.1% | 50 |
|
|
2013
Q4 | $1.19M | Buy |
+22,521
| New | +$1.11M | 1.14% | 44 |
|
Other funds holding ABBV
Wunderlich Capital Managemnt's ABBV Position: Q2 2024 in Review
Wunderlich Capital Managemnt increased its AbbVie (ABBV) stake by 0.81% in Q2 2024, buying an estimated $7.95K and bringing the position to 6,003 shares worth $1.03M. The position accounts for 0.46% of the portfolio, ranked #60.
Wunderlich Capital Managemnt first reported a position in ABBV in Q4 2013 and has held it in 33 quarters since. The position peaked at $2.28M in Q4 2017. 3,365 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.
- Wunderlich Capital Managemnt held 6,003 shares of AbbVie worth $1.03M as of Q2 2024.
- Wunderlich Capital Managemnt bought 48 AbbVie shares in Q2 2024, an estimated $7.95K.
- AbbVie made up 0.46% of Wunderlich Capital Managemnt's portfolio in Q2 2024, its #60 holding.
- Wunderlich Capital Managemnt first reported a position in AbbVie in Q4 2013 and has held it in 33 quarters since.
- Wunderlich Capital Managemnt's AbbVie position peaked at $2.28M in Q4 2017.
- 3,365 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.
Based on Wunderlich Capital Managemnt's 13F filing for Q2 2024, filed 14 Aug 2024.